Huntsman (NYSE:HUN – Get Free Report) had its price target reduced by research analysts at Wells Fargo & Company from $22.00 to $20.00 in a report released on Friday, MarketBeat Ratings reports. The brokerage presently has an “overweight” rating on the basic materials company’s stock. Wells Fargo & Company‘s price objective points to a potential upside of 42.96% from the stock’s previous close.
Other equities research analysts have also issued research reports about the company. Citigroup lowered their target price on Huntsman from $22.00 to $19.00 and set a “neutral” rating for the company in a research note on Wednesday, December 18th. Alembic Global Advisors cut shares of Huntsman from an “overweight” rating to a “neutral” rating in a report on Wednesday, January 15th. Mizuho reduced their price target on shares of Huntsman from $23.00 to $21.00 and set a “neutral” rating for the company in a research report on Tuesday, January 7th. Royal Bank of Canada upped their price objective on Huntsman from $17.00 to $18.00 and gave the stock a “sector perform” rating in a research note on Thursday, February 20th. Finally, The Goldman Sachs Group lowered their price target on Huntsman from $22.00 to $19.00 and set a “sell” rating on the stock in a report on Wednesday, March 5th. One investment analyst has rated the stock with a sell rating, six have issued a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $20.25.
View Our Latest Stock Report on Huntsman
Huntsman Trading Down 9.9 %
Huntsman (NYSE:HUN – Get Free Report) last issued its quarterly earnings results on Monday, February 17th. The basic materials company reported ($0.25) EPS for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.18). Huntsman had a negative net margin of 3.13% and a negative return on equity of 0.39%. The firm had revenue of $1.45 billion for the quarter, compared to analysts’ expectations of $1.45 billion. As a group, equities analysts forecast that Huntsman will post 0.32 EPS for the current fiscal year.
Hedge Funds Weigh In On Huntsman
Large investors have recently made changes to their positions in the business. Wealth Enhancement Advisory Services LLC increased its position in shares of Huntsman by 1.8% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 38,070 shares of the basic materials company’s stock valued at $686,000 after acquiring an additional 674 shares during the period. Quadrant Capital Group LLC increased its holdings in Huntsman by 74.9% in the 4th quarter. Quadrant Capital Group LLC now owns 2,232 shares of the basic materials company’s stock worth $40,000 after buying an additional 956 shares during the period. PNC Financial Services Group Inc. increased its stake in shares of Huntsman by 4.0% in the fourth quarter. PNC Financial Services Group Inc. now owns 31,694 shares of the basic materials company’s stock worth $571,000 after acquiring an additional 1,212 shares during the period. Mariner LLC raised its holdings in shares of Huntsman by 10.0% during the fourth quarter. Mariner LLC now owns 13,550 shares of the basic materials company’s stock worth $244,000 after purchasing an additional 1,233 shares during the last quarter. Finally, Bridgefront Capital LLC boosted its holdings in Huntsman by 16.7% in the fourth quarter. Bridgefront Capital LLC now owns 11,120 shares of the basic materials company’s stock valued at $200,000 after purchasing an additional 1,594 shares during the last quarter. 84.81% of the stock is owned by institutional investors and hedge funds.
Huntsman Company Profile
Huntsman Corporation manufactures and sells diversified organic chemical products worldwide. The company operates in three segments: Polyurethanes, Performance Products, and Advanced Materials. The Polyurethanes segment offers polyurethane chemicals, including methyl diphenyl diisocyanate, polyether and polyester polyols, and thermoplastic polyurethane; and aniline, benzene, nitrobenzene and other co-products.
Read More
- Five stocks we like better than Huntsman
- How to Know if a Stock Pays Dividends and When They Are Paid Out
- Tariffs, Spin-Out, and R2 Updates Are Positive Signs for Rivian
- Consumer Staples Stocks, Explained
- Cathie Wood Loads Up on Baidu—Is It the Right Time to Buy?
- What is MarketRank™? How to Use it
- Big Buybacks: 3 Large Caps Exceed 5% Repurchase Power
Receive News & Ratings for Huntsman Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Huntsman and related companies with MarketBeat.com's FREE daily email newsletter.